Q4 2023 Apellis Pharmaceuticals Inc Earnings Call Transcript

Feb 27, 2024 / 01:30PM GMT
Operator

Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals Fourth Quarter 2023 Earnings Conference Call. (Operator Instructions) Please be advised today's conference is being recorded.

I would now hand the conference over to your speaker host, Meredith Kaya, Senior Vice President, Investor Relations & Strategic Finance. Please go ahead.

Meredith Kaya - Apellis Pharmaceuticals, Inc. - SVP, IR & Strategic Finance

Good morning, and thank you for joining us to discuss Apellis' fourth quarter and full year 2023 financial results. With me on the call are: Co-Founder and Chief Executive Officer, Dr. Cedric Francois, Chief Operating Officer, Adam Townsend; Chief Medical Officer, Dr. Caroline Baumal; and Chief Financial Officer, Tim Sullivan.

Before we begin, let me point out that we will be making forward-looking statements that are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties. And actual results may differ materially. I encourage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot